Major Northeast health system takes ‘huge step forward’ with Sectra’s digital pathology solution

Cleveland-based healthcare system MetroHealth plans to incorporate Sectra’s digital pathology solution across its entire imaging enterprise, the pair announced on Tuesday.

Initially, the implementation will key in on developing quality assurance workflows within pathology, integrating with tumor boards, and establishing a teaching and research database for the system’s 13 pathologists and nine residents. By doing so, providers will have the ability to analyze cases from any location, including their own homes.

“By offering integration of whole scanned slides and radiology images on one platform, Sectra represents a huge step forward in patient care,” Department Chair of Pathology at The MetroHealth System Agnes Loeffler, MD, said in an email statement.

The nonprofit system is one of the largest employers in Northeast Ohio, with a staff of 7,800 providing care at four hospitals and 40 additional sites. Each practicing physician also holds a faculty appointment at Case Western Reserve University School of Medicine.

Medical imaging IT and cybersecurity company Sectra received U.S. Food and Drug Administration approval for its digital pathology solution in March. In a busy year, the firm also won a contract to install its digital module across the entire Mayo Clinic enterprise and won a contract to install its radiology and breast imaging modules at Mayfair Diagnostics, a Canadian teleradiology giant.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.